 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stock analysts at StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD - Get Free Report) in a research note issued to investors on Thursday. The brokerage set a "sell" rating on...

Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD - Free Report) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the medical...

Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD  Get Free Report) in a report released on Wednesday. The brokerage set a sell rating on the medical...

Aethlon Medical, Inc. (NASDAQ:AEMD  Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling...

Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Expands By 33.8%

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aethlon Medical files to sell common stock, warrants, no amount given

Analysts at StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD  Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a...

StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD)

StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD  Free Report) in a report published on Monday. The brokerage issued a sell rating on the medical equipment...

Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com

Aethlon Medical (NASDAQ:AEMD  Get Free Report) had its target price lowered by HC Wainwright from $23.00 to $10.00 in a report released on Monday, Benzinga reports. The firm presently has a...

Aethlon Medical (NASDAQ:AEMD) PT Lowered to $10.00

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Connect Biopharma Holdings (CNTB Research Report), Aethlon Medical...

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.

Volume (M)	1,631.00
52-Wk High	$7.20
52-Wk Low	$1.35

AEMD Aethlon Medical Inc

About

Feed

News

Sentiment

Earnings

Fundamentals